Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
39
39 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- REGN7508CenvacibartPhase 312 trials
Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism
- LP-003SinglePhase 39 trials
Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies
- hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials
Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)
- AbelacimabMAA868Phase 33 trials
Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke
- MilvexianJNJ-70033093, BMS-986177Phase 33 trials
Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome
- TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials
Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke
- MLC1501Phase 32 trials
Moleac Pte Ltd. · Stroke, Stroke, Ischemic, Strokes Thrombotic
- SovateltideIRL-1620, PMZ-1620Phase 32 trials
Pharmazz, Inc. · Traumatic Brain Injury, Acute Ischemic Stroke, Cerebral Stroke
- JX10Phase 31 trial
Corxel Pharmaceuticals · Acute Ischemic Stroke
- non-immunogenic staphylokinasePhase 31 trial
Supergene, LLC · Ischemic Stroke, Acute
- OtaplimastatSP-8203Phase 31 trial
Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke
- Recombinant Human ProurokinaserhPro-UKPhase 31 trial
Tasly Biopharmaceuticals Co., Ltd. · Acute Ischemic Stroke AIS
- SHPL-49Phase 31 trial
Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke
- SIM0811Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Acute Ischemic Stroke AIS
- NeflamapimodVX-745Phase 24 trials
EIP Pharma Inc · Nonfluent Variant Primary Progressive Aphasia (nfvPPA), Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke
- RimonabantPhase 24 trials
Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- Umbilical Cord Mesenchymal Stem CellsMesenchymal stromal cells, Allogeneic Mesenchymal Stem CellsPhase 24 trials
PT. Prodia Stem Cell Indonesia · Diabetic Nephropathy Type 2, Ischemic Stroke, Cerebral Palsy
- LT3001Phase 23 trials
Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke
- ALT001Phase 22 trials
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)
- LT3001 DrugPhase 22 trials
Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke
- TS23Phase 22 trials
Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism
- TTI-0102cysteamine-pantetheine disulfidePhase 22 trials
Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome
- ASP2246Phase 21 trial
Astellas · Chronic Ischemic Stroke
- B2065Phase 21 trial
Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke
- BB-031DTRI-031Phase 21 trial
Basking Biosciences, Inc. · Acute Ischemic Stroke
- HRS-4029Phase 21 trial
Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke
- HRS-7450Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke
- IW-6463CY6463, zagociguatPhase 21 trial
Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
- MT200605Phase 21 trial
Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke
- NCS-01Phase 21 trial
NC Medial Research Inc · Ischemic Stroke
- NoNO-42Phase 21 trial
NoNO Inc. · Acute Ischemic Stroke
- NTS-521Phase 21 trial
NeuroTrauma Sciences, LLC · Acute Ischemic Stroke
- QD202Phase 21 trial
Shanghai QuietD Biotechnology Co., Ltd. · Acute Ischemic Stroke
- QHRD106MiddlePhase 21 trial
Changzhou Qianhong Bio-pharma Co., Ltd. · Acute Ischemic Stroke
- RedasemtideRedasemtide trifluoroacetate, S-005151Phase 21 trial
Shionogi · Acute Ischemic Stroke
- scp776allPhase 21 trial
Silver Creek Pharmaceuticals · Acute Ischemic Stroke (AIS)
- TBO-309Phase 21 trial
ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion
- XY03-EAper dosePhase 21 trial
Shijiazhuang Yiling Pharmaceutical Co. Ltd · Stroke, Ischemic
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.